Thao Doan

903 total citations
35 papers, 543 citations indexed

About

Thao Doan is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Thao Doan has authored 35 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 8 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Thao Doan's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Microscopic Colitis (5 papers). Thao Doan is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Microscopic Colitis (5 papers). Thao Doan collaborates with scholars based in United States, Vietnam and United Kingdom. Thao Doan's co-authors include George J. Hanna, Yi‐Lin Chiu, Cheri E. Klein, Tong Zhu, John B. Morris, Randall W. Nelson, Scott C. Brun, Walid M. Awni, Kun Zeng and John S. Mitchell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Thao Doan

30 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thao Doan United States	13	126	99	80	77	77	35	543
Evan M. Cadoff United States	11	104 0.8×	94 0.9×	125 1.6×	116 1.5×	26 0.3×	22	530
Soraya Fellahi France	17	162 1.3×	184 1.9×	133 1.7×	85 1.1×	27 0.4×	34	774
Sarah Allegra Italy	16	248 2.0×	203 2.1×	131 1.6×	59 0.8×	24 0.3×	59	801
Ron van Schaik Netherlands	9	173 1.4×	48 0.5×	104 1.3×	34 0.4×	25 0.3×	29	553
Grant Langdon United Kingdom	12	293 2.3×	167 1.7×	127 1.6×	46 0.6×	30 0.4×	28	736
Joaquín Borrás‐Blasco Spain	15	55 0.4×	110 1.1×	36 0.5×	58 0.8×	57 0.7×	61	618
Keith Nieforth United States	16	214 1.7×	249 2.5×	137 1.7×	51 0.7×	18 0.2×	31	792
Nastya Kassir United States	13	33 0.3×	72 0.7×	69 0.9×	48 0.6×	37 0.5×	46	400
Lawrence Galitz United States	8	87 0.7×	149 1.5×	74 0.9×	38 0.5×	37 0.5×	12	480
Marie‐Claude Gagnieu France	19	278 2.2×	273 2.8×	169 2.1×	97 1.3×	18 0.2×	63	889

Countries citing papers authored by Thao Doan

Since Specialization

Citations

This map shows the geographic impact of Thao Doan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thao Doan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thao Doan more than expected).

Fields of papers citing papers by Thao Doan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thao Doan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thao Doan. The network helps show where Thao Doan may publish in the future.

Co-authorship network of co-authors of Thao Doan

This figure shows the co-authorship network connecting the top 25 collaborators of Thao Doan. A scholar is included among the top collaborators of Thao Doan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thao Doan. Thao Doan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dang, Anh Kim, et al.. (2025). Tumor-infiltrating lymphocytes are the key determinants of pathological features associated with pathogenic BRCA variants in high-grade serous ovarian carcinoma. Frontiers in Medicine. 12. 1555883–1555883.

Ngo, Hanh, et al.. (2025). Early Recurrence of Hepatocellular Carcinoma in Patients without Microscopic Vascular Invasion: Clinicopathological Characteristics and Risk Factors. Journal of Hepatocellular Carcinoma. Volume 12. 1167–1175.

Merrill, Joan T., Amit Saxena, Martin Aringer, et al.. (2025). OP0198 EFFICACY AND SAFETY OF ABBV-599 (ELSUBRUTINIB AND UPADACITINIB COMBINATION) AND UPADACITINIB MONOTHERAPY FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS THROUGH 104 WEEKS IN A LONG-TERM EXTENSION STUDY. Annals of the Rheumatic Diseases. 84. 163–165.

Doan, Thao, et al.. (2024). Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam. Journal of Pathology and Translational Medicine. 58(4). 174–181.

Merrill, Joan T., Yoshiya Tanaka, David D’Cruz, et al.. (2024). Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial. Arthritis & Rheumatology. 76(10). 1518–1529. 21 indexed citations

Ferguson, Monique R., et al.. (2023). Coronavirus Disease 2019, Diabetes, and Inflammation: A Systemic Review. Metabolic Syndrome and Related Disorders. 21(4). 177–187. 4 indexed citations

Tran, Giang Huong, et al.. (2023). Concordance of Clinical, Histologic and Direct Immunofluorescence Findings in Patients with Autoimmune Bullous Dermatoses in Vietnam. SHILAP Revista de lepidopterología. 10(1). 30–40. 1 indexed citations

Fleischmann, R., Alan Friedman, Edit Drescher, et al.. (2022). Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial. The Lancet Rheumatology. 4(6). e395–e406. 8 indexed citations

Vuong, Lan N., et al.. (2022). A Community-Based Model of Care During the Fourth Wave of the COVID-19 Outbreak in Ho Chi Minh City, Vietnam. Frontiers in Artificial Intelligence. 5. 831841–831841. 2 indexed citations

10.

Doan, Thao, et al.. (2021). Bilateral adrenal masses due to tuberculosis: how to diagnose without extra-adrenal tuberculosis. Endocrinology Diabetes and Metabolism Case Reports. 2021. 5 indexed citations

11.

Chen, Baili, Xiang Gao, Jie Zhong, et al.. (2020). Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn’s disease: results from a randomized trial. Therapeutic Advances in Gastroenterology. 13. 3974127824–3974127824. 27 indexed citations

12.

Danese, Silvio, William J. Sandborn, Edward V. Loftus, et al.. (2020). S0648 Clinically Adjusted vs Therapeutic Drug Monitoring Dosing Regimens With Adalimumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the SERENE-CD Maintenance Study. The American Journal of Gastroenterology. 115(1). S325–S326. 5 indexed citations

13.

Cao, Ngọc Thành, et al.. (2019). Reactive Hemophagocytic Lymphohistiocytosis-Associated Kikuchi-Fujimoto Disease After a Staphylococcus epidermidis Cutaneous Infection. JCR Journal of Clinical Rheumatology. 27(3). e96–e97. 3 indexed citations

14.

Klein, Cheri E., Yi‐Lin Chiu, Kathryn R. King, et al.. (2008). Effects of Acid‐Reducing Agents on the Pharmacokinetics of Lopinavir/Ritonavir and Ritonavir‐Boosted Atazanavir. The Journal of Clinical Pharmacology. 48(5). 553–562. 36 indexed citations

15.

Al-Salihi, Mazin A., A. Terrece Pearman, Thao Doan, et al.. (2008). Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression. Cancer Letters. 273(2). 225–232. 31 indexed citations

16.

Klein, Cheri E., Yi‐Lin Chiu, Walid M. Awni, et al.. (2007). The Tablet Formulation of Lopinavir/Ritonavir Provides Similar Bioavailability to the Soft-Gelatin Capsule Formulation With Less Pharmacokinetic Variability and Diminished Food Effect. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(4). 401–410. 117 indexed citations

17.

Al-Salihi, Mazin A., et al.. (2007). Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and Tumor Necrosis Factor-α converting enzyme. Cellular Signalling. 19(9). 1956–1963. 22 indexed citations

18.

Xiong, Hao, Robert A. Carr, Charles Locke, et al.. (2007). Dual Effects of Rifampin on the Pharmacokinetics of Atrasentan. The Journal of Clinical Pharmacology. 47(4). 423–429. 26 indexed citations

19.

Doan, Thao. (2003). Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells. Cellular Signalling. 16(3). 301–311. 16 indexed citations

20.

Doan, Thao, et al.. (2001). Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects. American Journal of Health-System Pharmacy. 58(16). 1512–1519. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact